Deborah Mash is a professor Neurology and Molecular and Cellular Pharmacology at the University of Miami School of Medicine. She is also the Chief Executive Officer and founder of clinical stage pharmaceutical development company DemeRx. Her research is focused on the potential use of ibogaine for opioid and other substance abuse disorders.
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)